Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950109-02-001867
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 d10k405.htm 10-K405 849164
3 CERTIFICATE OF CORRECTION dex33.htm EX-3.3 4863
4 CERTIFICATE OF INCORPORATION dex34.htm EX-3.4 4507
5 AMENDMENT CERTIFICATION OF DESIGNATION 02/18/2000 dex45.htm EX-4.5 5400
6 AMENDMENT TO CERTIFICATE OF DESIGNATION 05/01/2000 dex46.htm EX-4.6 5616
7 AMENDMENT TO CERTIFICATE OF DESIGNATION dex47.htm EX-4.7 8219
8 CONSENT OF ERNST AND YOUNG dex231.htm EX-23.1 1913
  Complete submission text file 0000950109-02-001867.txt   881925
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
RIBOZYME PHARMACEUTICALS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-27914 | Film No.: 02596838
SIC: 2834 Pharmaceutical Preparations